Hernando Salcedo’s experience is drawing attention to how a clinical trial can change the outlook for some pancreatic cancer patients. The 83-year-old grandfather, described as healthy and active, became concerned after noticing stomach swelling in May 2025.
According to the report, his diagnosis was Stage III pancreatic cancer. The story highlights how the warning signs were not dramatic at first, with only mild symptoms and recent hip pain before doctors identified the disease.
Salcedo’s early treatment was difficult. Chemotherapy reportedly left him feeling worse than he had before learning he had pancreatic cancer, underscoring how hard standard treatment can be for patients with advanced disease.
The turning point came when a clinical trial offered another option. CBS News said that the trial helped Salcedo beat the odds, making his case a notable example of why experimental cancer treatments and research studies remain important for people facing late-stage pancreatic cancer.
